We are live on ! Find out more
GIC

Generali Investments CEE Portfolio holdings

AUM $2.11B
1-Year Est. Return 25.53%
This Fund
S&P 500
This Quarter Est. Return
-0.1%
1 Year Est. Return
+25.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.91B
AUM Growth
+$488M
Cap. Flow
+$503M
Cap. Flow %
26.37%
Top 10 Hldgs %
20.77%
Holding
462
New
66
Increased
94
Reduced
109
Closed
10

Top Buys

Rank Stock Value
1
B
Barrick Mining
B
+$6.9M
2
MSFT icon
Microsoft
MSFT
+$4.97M
3
DELL icon
Dell
DELL
+$4.38M
4
AVGO icon
Broadcom
AVGO
+$4.18M
5
AZN icon
AstraZeneca
AZN
+$2.96M

Top Sells

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$9.27M
2
VTRS icon
Viatris
VTRS
+$3.22M
3
SSL icon
Sasol
SSL
+$3.06M
4
MSCI icon
MSCI
MSCI
+$2.58M
5
RY icon
Royal Bank of Canada
RY
+$2.25M

Sector Composition

Rank Sector Weight
1 Technology 10.65%
2 Financials 6.27%
3 Consumer Discretionary 5.18%
4 Healthcare 4.62%
5 Communication Services 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRSH
201
Marsh
MRSH
$91.5B
$760K 0.04%
4,383
+256
+6% +$46K
ILMN icon
202
Illumina
ILMN
$28.4B
$740K 0.04%
6,000
– –
MSCI icon
203
MSCI
MSCI
$40.9B
$728K 0.04%
1,350
-4,583
-77% -$2.58M
DVN icon
204
Devon Energy
DVN
$47.3B
$699K 0.04%
13,900
– –
D icon
205
Dominion Energy
D
$59.3B
$692K 0.04%
11,200
– –
GEV icon
206
GE Vernova
GEV
$264B
$690K 0.04%
+790
New +$616K
VTRS icon
207
Viatris
VTRS
$18.9B
$676K 0.04%
50,008
-229,735
-82% -$3.22M
AGI icon
208
Alamos Gold
AGI
$13.9B
$659K 0.03%
14,836
– –
FSK icon
209
FS KKR Capital
FSK
$3.44B
$658K 0.03%
64,650
– –
ISRG icon
210
Intuitive Surgical
ISRG
$134B
$653K 0.03%
1,416
-132
-9% -$66.8K
MRNA icon
211
Moderna
MRNA
$23.6B
$645K 0.03%
12,700
– –
NVO
212
Novo Nordisk
NVO
$209B
$640K 0.03%
17,413
-4,062
-19% -$192K
TDG icon
213
TransDigm Group
TDG
$67.7B
$637K 0.03%
550
+216
+65% +$283K
RGLD icon
214
Royal Gold
RGLD
$19.5B
$636K 0.03%
2,500
– –
BMNR
215
BitMine Immersion Technologies
BMNR
$11.4B
$633K 0.03%
32,000
+5,600
+21% +$132K
LIN icon
216
Linde
LIN
$226B
$626K 0.03%
1,263
-504
-29% -$238K
MKL icon
217
Markel Group
MKL
$23.2B
$622K 0.03%
325
– –
CDE icon
218
Coeur Mining
CDE
$17.9B
$621K 0.03%
33,073
+3,487
+12% +$75.9K
TEVA icon
219
Teva Pharmaceuticals
TEVA
$41.2B
$614K 0.03%
20,400
– –
HWM icon
220
Howmet Aerospace
HWM
$112B
$599K 0.03%
2,599
– –
AG icon
221
First Majestic Silver
AG
$9.07B
$585K 0.03%
27,233
– –
MTD icon
222
Mettler-Toledo International
MTD
$28.6B
$580K 0.03%
460
– –
DB icon
223
Deutsche Bank
DB
$71.5B
$555K 0.03%
+18,658
New +$657K
ZBH icon
224
Zimmer Biomet
ZBH
$18.4B
$552K 0.03%
6,100
– –
MRVL icon
225
Marvell Technology
MRVL
$196B
$525K 0.03%
5,300
– –
7 8
9
10 11

Similar funds

IVAV
Index Venture Associates VI St. Helier, Channel Islands, Jersey $2.11B AUM 13.76% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CF
Centaurus Financial Anaheim, California $2.1B AUM 21.28% 1-Year Est. Return
BWC
Blue Whale Capital London, United Kingdom $2.1B AUM 97.03% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Generali Investments CEE's Q1 2026 Portfolio in Review

As of Q1 2026, Generali Investments CEE held 462 positions worth $1.91B, up 34% from $1.42B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Generali Investments CEE deployed $503M of net new capital in Q1 2026, opening 66 new positions and adding to 94 existing holdings. Its largest new stake was AstraZeneca: 15,328 shares worth $2.98M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Viatris, an estimated $3.22M trimmed.

  • Generali Investments CEE's largest Q1 2026 buy was AstraZeneca: 15,328 shares worth $2.98M.
  • Generali Investments CEE added most to Barrick Mining in Q1 2026, an estimated $6.9M increase.
  • Generali Investments CEE's biggest Q1 2026 reduction was Viatris, cutting an estimated $3.22M.
  • Generali Investments CEE fully exited iShares Core MSCI Emerging Markets ETF in Q1 2026, selling an estimated $9.27M.
  • Generali Investments CEE's ten largest holdings make up 21% of its $1.91B portfolio in Q1 2026.
  • Generali Investments CEE opened 66 new positions and closed 10 in Q1 2026.
  • Generali Investments CEE's portfolio value rose 34% quarter-over-quarter to $1.91B.

Based on Generali Investments CEE's 13F filing for Q1 2026, filed 15 Apr 2026.